Clinical Trial Update: Safety Study of Subcutaneously-Injected Prandial INSULIN-PH20 NP Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 safety study comparing subcutaneous Prandial INSULIN-PH20 NP with insulin lispro in participants with Type 1 diabetes mellitus; the trial is completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Prandial INSULIN-PH20 NP
• insulin lispro (insulin lispro)

Snippet

Sponsor: Halozyme Therapeutics | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED | Results posted: 2014-09-08